Checkpoint Responses in Cancer Therapy

Editors:

ISBN: 978-1-58829-930-7 (Print) 978-1-59745-274-8 (Online)

Table of contents (13 chapters)

  1. Front Matter

    Pages I-XIII

  2. No Access

    Book Chapter

    Pages 1-17

    RB-Pathway

  3. No Access

    Book Chapter

    Pages 19-56

    Targeting the p53/MDM2 Pathway for Cancer Therapy

  4. No Access

    Book Chapter

    Pages 57-91

    DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer

  5. No Access

    Book Chapter

    Pages 93-116

    Targeting ATM/ATR in the DNA Damage Checkpoint

  6. No Access

    Book Chapter

    Pages 117-133

    Compounds that Abrogate the G2 Checkpoint

  7. No Access

    Book Chapter

    Pages 135-162

    CDK Inhibitors as Anticancer Agents

  8. No Access

    Book Chapter

    Pages 163-176

    CHFR as a Potential Anticancer Target

  9. No Access

    Book Chapter

    Pages 177-205

    Antimicrotubule Agents

  10. No Access

    Book Chapter

    Pages 207-226

    Kinesin Motor Inhibitors as Effective Anticancer Drugs

  11. No Access

    Book Chapter

    Pages 227-241

    Targeting the Spindle Checkpoint in Cancer Chemotherapy

  12. No Access

    Book Chapter

    Pages 243-269

    Antiproliferation Inhibitors Targeting Aurora Kinases

  13. No Access

    Book Chapter

    Pages 271-290

    Plks as Novel Targets for Cancer Drug Design

  14. No Access

    Book Chapter

    Pages 291-309

    Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?

  15. Back Matter

    Pages 311-314